Frontiers | An Overview of in vitro Methods to Study Microglia | Cellular Neuroscience
Recent Expansions on Cellular Models to Uncover the Scientific Barriers Towards Drug Development for Alzheimer's Disease | SpringerLink
Brain organoids: a next step for humanized Alzheimer's disease models? | Molecular Psychiatry
![PDF] Animal models of Alzheimer's disease and frontotemporal dementia | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3001a2c4a156c34623702a97230e9f6aabaa4b4b/9-Figure4-1.png "PDF] Animal models of Alzheimer's disease and frontotemporal dementia | Semantic Scholar")
PDF] Animal models of Alzheimer's disease and frontotemporal dementia | Semantic Scholar
Schematic of the major animal models of Alzheimer's disease. Less than... | Download Scientific Diagram
Expression of ACAT1 in Alzheimer Disease mouse and cell models. (A) The... | Download Scientific Diagram
GABAeron Presents Promising Preclinical Data on Stem Cell-Based Therapy for Alzheimer's Disease
Recent Expansions on Cellular Models to Uncover the Scientific Barriers Towards Drug Development for Alzheimer's Disease | SpringerLink
Frontiers | Microglia in Alzheimer Disease: Well-Known Targets and New Opportunities | Aging Neuroscience
Stem Cell Therapies in Alzheimer's Disease: Applications for Disease Modeling | Journal of Pharmacology and Experimental Therapeutics
Dementia Insights: What Do Animal Models of Alzheimer's Disease Tell Us? - Practical Neurology
In Vivo Chimeric Alzheimer's Disease Modeling of Apolipoprotein E4 Toxicity in Human Neurons - ScienceDirect
Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease | PNAS
Quantitative in vivo assessment of amyloid-beta phagocytic capacity in an Alzheimer's disease mouse model - ScienceDirect
Amyloid‐β oligomers in cellular models of Alzheimer's disease - Fontana - 2020 - Journal of Neurochemistry - Wiley Online Library
Can mouse models mimic sporadic Alzheimer's disease? Foidl BM, Humpel C - Neural Regen Res
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models: Cell
Deficiency of Neuronal p38α MAPK Attenuates Amyloid Pathology in Alzheimer Disease Mouse and Cell Models through Facilitating Lysosomal Degradation of BACE1* - Journal of Biological Chemistry
Counteracting the effects of TNF receptor‐1 has therapeutic potential in Alzheimer's disease | EMBO Molecular Medicine
Hallmarks of Alzheimer's Disease in Stem-Cell-Derived Human Neurons Transplanted into Mouse Brain: Neuron
APP mouse models for Alzheimer's disease preclinical studies | The EMBO Journal
A conformation-specific antibody against oligomeric β-amyloid restores neuronal integrity in a mouse model of Alzheimer's disease - Journal of Biological Chemistry
Chronic deep brain stimulation in an Alzheimer's disease mouse model enhances memory and reduces pathological hallmarks - Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation
miRNA-31 Improves Cognition and Abolishes Amyloid-β Pathology by Targeting APP and BACE1 in an Animal Model of Alzheimer's Disease - ScienceDirect
AT2R's (Angiotensin II Type 2 Receptor's) Role in Cognitive and Cerebrovascular Deficits in a Mouse Model of Alzheimer Disease | Hypertension
